Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
98 Cards in this Set
- Front
- Back
symptoms of gout
|
-hyperuricemia
-acute, recurring periods of arthritis -interstitial renal dz -uric acid nephrolithiasis |
|
incidence of gout is correlated w/ ...
|
age
serum Cr BUN male BP body weight alcohol intake |
|
risk factors for gout
|
-age
-SCr -BUN -male -BP -body weight -alcohol intake |
|
hyperuricemia is defined as a serum UA of .....
|
more than 7-7.5 mg/dl
|
|
hyperuricemia is due to ...
|
overproduction or underexcretion of UA
|
|
t/f hyperuricemia is always symptomatic
|
F
|
|
causes of primary overproduction
|
specific enzyme defects
see notes for exact enzymes |
|
causes of secondary overproduction
|
myelo-/lymphoproliferative disorders
infectious mononucleosis chronic hemolytic anemia |
|
causes of primary underexcretion
|
idiopathic
familial juvenile gouty nephropathy |
|
secondary causes of underexcretion
|
chronic renal mass/kidney injury
HTN sickle cell hypothyroid down's syndrome |
|
high consumption of ... seems protective for hyperuricemia
|
dairy products
|
|
t/f hyperuricemia risk inc. w/ eating meat/beer/seafood
|
T
|
|
what foods are beneficial for ppl w/ gout
|
high in complex carbs (fruits, veggies, whole grains)
low in protein (tofu) no more than 30% calories from fat (10% animal fat) - certain FAs from fish, flax, olive oil or nuts may have anti-inflamm benefits |
|
drugs that can induce hyperuricemia and gout
|
diuretics
salicylates cytotoxic drugs ethanol l-dopa pyrazinamide, ethambutol nicotinic acid, vit. B12 cyclosporine |
|
in later phases of gout attack more _____ arrive and do what?
|
macrophages
ingest urate crystals and release more inflamm mediators |
|
if untreated an acute gouty attack will last...
|
3-14 days
|
|
signs and symptoms of an acute gout attack
|
PAIN
erythema warmth swelling fever leukocytosis |
|
where does acute gout occur and why
|
peripheral joints of LE
low temp of joints and inc. intra-articular UA conc.-->at night water is reabsorbed leaving supersaturated sol'sn of urate which precipitates |
|
how many joints are initially involved in an acute attack?
which is the most often affected? |
1
1st MPJ then instep, ankles, heels, knees, wrist, fingers and elbows |
|
what can precipitate an acute attack
|
stress
trauma alcohol infxn sx rapid lowering of UA by drugs |
|
Dx of gout is best achieved ....
|
from aspiration of synovial fluid-->ID MSU monohydrate crystals in leukocytes
|
|
what renal complications are seen in gout
|
nephrolithiasis
gouty nephropathy (acute and chronic) HTN nephrosclerosis |
|
what % of gout pts get kidney stones
|
10-25%
|
|
t/f kidney stones in gout pts are made of UA
|
F
can be UA, UA/Ca oxalate or pure Ca oxalate |
|
UA stones are radiolucent/opaque?
Ca oxalate? |
UA- lucent
Ca- opaque |
|
predisposing factors for nephrolithiasis
|
-excess urinary excretion of UA
-acidic/highly conc. urine (pH of less than 6) -->spontaneous precipitation of stones |
|
what is acute gouty nephropathy and how do you treat it
|
when urine flow is blocked by massive precip. of UA crystals in collecting ducts or ureters (can occur after chemo)
allopurinol dec./prevents nephropathy |
|
what causes chronic gouty nephropathy
|
long-term deposition of urate crystals in renal parenchyma, microtophi may form
also see HTN and nephrosclerosis commonly |
|
t/f hyperuricemia is in itself harmful to kidneys
|
F,
prolly not |
|
t/f chronic gouty nephropathy is reversible if gout is treated
|
F
irreversible |
|
t/f tophaceous gout is common among gout pts
|
F
a late complicaiton uncommon in general pop. of gout pts |
|
t/f tophaceous gout can cause carpal tunnel syndrome
|
T
|
|
what problems do tophi cause
|
deformities
ST damage joint destruction pain nerve compression syndromes |
|
most common sites for tophi
|
base of great toe
helix of ear olecranon bursae achilles knees wrists hands |
|
t/f long-term drug tx in an asymptomatic hyperuricemic pt can be helpful
|
F
|
|
t/f treat hyperuricemia when treating an acute attack
|
F
|
|
tx plan for acute gout
|
initial NSAIDs
steroids if 1-2 joints colchicine used in onset of acute attack |
|
where does colchicine come from
|
autumn crocus
it's an alkaloid |
|
t/f colchicine has no effect on UA
|
t
|
|
how long does it take for colchicine to relieve pain and inflamm
|
12-24 hrs
|
|
what is the traditional drug for treating pain and inflamm of acute gouty arthritis
|
colchicine
|
|
what are all the uses for colchicine
|
acute gouty arthritis
prophylaxis of recurrent GArth. preventing acute mediterranean fever sarcoid arthritis |
|
MOA of colchicine
|
-anti-inflamm thru binding intracellular protein tubulin -->prevents polymerization into microtubules
-inhibit leukocyte migration, phagocytosis and LT B4 formation |
|
ADRs of colchicine
|
diarrhea*, NV,
acute intoxication (bloody diarrhea, shock, hematuria, oliguria, burning throat) fatal ascending CNS depression hair loss bone marrow depression |
|
GI toxicity occurs in _____% of pts before relief of attack
|
50-80
|
|
what ADR of colchicine is specific to the elderly
|
severe dehydration from diarrhea
serious electrolyte loss and death |
|
t/f bioavailablity of colchicine is good
|
F
25-50% |
|
give colchicine early or late in attack?
|
earlier is better*
|
|
colchicine is dosed until...
|
symptoms subside or NVD is intolerable
|
|
what is the max dose of IV colchicine
|
4 mg
|
|
what do you need to do if you're giving colchicine IV
|
dilute dose in 20 ml of normal saline to prevent sclerosis
|
|
who should not get colchicine IV
|
neutropenic pts
difficult to inject veins severe renal imparment (CrCL <10) combined renal/hepatic insufficiency |
|
___% of acute arthr. pts respond to colchicine w/in ____ hrs of onset.
after ___ hrs. after onset, don't bother w/ colchicine |
75-90%
12 hrs 24 hrs |
|
t/f clinical response to colchicine is pathognomonic for gout
|
F
|
|
no additional colchicine should be given for ___ days and oral colchicine should be d/c b/c of ...
|
7 days
risk of bone marrow toxicity |
|
MOA of NSAIDs in gout
|
inhibit PG synth and urate crystal phagocytosis
|
|
t/f you can use all NSAIDs to treat gout
|
F
not ASA |
|
which NSAID lowers serum UA levels
|
oxaprozin
|
|
when should you not use oxaprozin
|
during active attack
can lead to crystal deposition |
|
what pts should not take oxaprozin
|
pts /w UA stones
|
|
t/f newer NSAIDs are just as effective and safe as older drugs
|
T
|
|
what NSAID is most often used to treat acute gout
|
indomethacin
|
|
what drug is an alternative to colchicine for initial treatment of acute gout
|
indomethacin
|
|
how do you dose indomethacin?
why? |
large dose for first 24 hrs then taper therapy over 3-5 days
to dec. risk of recurrent attack and to dec. risk of kidney damage |
|
don't give indomethacin to ...? why?
|
elderly
b/c of PG inhibition in the kidney --> dec. kidney fxn* |
|
name the uricosuric agents
|
probenecid
sulfinpyrazone |
|
uricosurics are good for what pts?
|
evidence of tophi
several acute attacks high plasma UA levels (tissue damage is inevitable) |
|
when after acute attack do you start uricosurics and why
|
2-3 weeks after attack
can cause precipitation of UA calculi/tophi or another attack in pts who excrete lots of UA |
|
w/ uricosurics it is important to maintain____ to dec. risk of ...
|
large urine volume
stone formation |
|
what drug may be used as an alternative to allopurinol
|
uricosurics*
|
|
t/f uricosurics are good for pts w/ dec. renal fxn
|
F*
|
|
MOA of uricosurics
|
affect active transport so less of the filtered UA is reabsorbed and more is excreted
|
|
ADRs of uricosurics
|
GI (esp. sulf.)
rash (prob. more likely to cause allergic dermatitis) nephrotic syndrome from prob. aplastic anemia (both) |
|
which is used more, sulfinpyrazone or probenecid
|
prob b/c of sulf.'s ADRs
|
|
what is special about fenofibrate
|
lowers lipids and UA
|
|
t/f uricosuric effect of fenofibrate is independent of lipid lowering effect
|
T
|
|
what does losartan do
|
it's an ARB for HTN
also uricosuric also inc. urine pH which stops supersaturation and risk of stones/nephropathy is less |
|
MOA of allopurinol
|
dec. UA synth by inhibiting xanthine oxidase
pre-UA proteins are more soluble in urine |
|
t/f allopurinol only works for overproducers
|
F
works for both |
|
t/f tx w/ allopurinol goes on for years or even lifelong
|
t
|
|
besides gout, allopurinol is used for
|
antiprotozoal
prevent massive uricosuria following blood dyscrasias (chemo) |
|
indications for allopurinol
|
chronic tophaceous gout
pts w/ 24 hr. UA >600-700 mg intolerance/ineffective uricosurics recurrent renal stones pt w/ renal fxn impairment grossly elevated serum UA levels |
|
t/f allopurinol is more effective in older pts
|
F
younger |
|
initial response to allopurinol is seen in ___ days, with peak in _____ days
|
2-3
7-10 |
|
ADRs of allopurinol
|
NVD
allergic skin rxn acute attacks of GArth. peripheral neuritis bone marrow depression aplastic anmeia hepatic toxicity interstitial nephritis |
|
what should be given for the first weeks of tx w/ allopurinol and why
|
colchicine or an NSAID
to prevent GArth that can occur |
|
what is febuxostat
|
XO inhibitor for managing chronic hyperuricemia in gout pts
|
|
ADRs of febuxostat
|
upper resp. tract infxn
diarrhea muscle and CT symptoms |
|
t/f febuxostat interacts w/ other gout meds
|
F
no interxn w/ colchicine, naproxen or indomethacin |
|
DDIs of febuxostat
|
can block clearance of other xanthine-based drugs
azathioprine theophylline |
|
what is rasburicase
|
non-pegylated recombinant urate oxidase
used for tumor lysis syndrome |
|
MOA of rasburicase
|
oxidizes urate to allantoin (highly soluble in urine)
breaks down preexisting UA (allopurinol doesn't) |
|
when do you start prophylaxis after first episode
|
severe attack of GArth
UA lithiasis serum UA of >10 24 hr. urine UA of >1000 |
|
how many attacks do you need to have before starting prophylaxis
|
more than 2-3 per year
even if serum UA is normal |
|
t/f never start prophylaxis if the serum UA is normal
|
F
|
|
how is colchicine used in prophylaxis
|
low dose oral BID if no visible tophi
at beginning of attack increase dose to q 2 hrs |
|
the goal of antihyperuricemic tx is to get serum UA below...
|
6 mg/dl
well below saturation point |
|
pt has recurrent acute GArth and significantly elevated. how do you manage it?
|
uric acid lowering tx
|